Page last updated: 2024-11-05

tyramine and Diabetic Nephropathies

tyramine has been researched along with Diabetic Nephropathies in 1 studies

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, S1
Cao, M1
Wu, G1
Long, Z1
Cheng, X1
Fan, J1
Xu, Z1
Su, H1
Hao, Y1
Li, G1
Peng, J1
Li, S1
Wang, X1

Other Studies

1 other study available for tyramine and Diabetic Nephropathies

ArticleYear
Hordenine protects against hyperglycemia-associated renal complications in streptozotocin-induced diabetic mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 104

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dia

2018